Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 7, 2008

View Archived Issues

The low-molecular-weight thiol pantethine confers protection against cerebral malaria

Shigella gastroenteritis vaccine immunogenic in phase I study

Salsalate reduces glycemia in obese subjects

ReNeuron schedules meeting with FDA to resolve IND hold for ReN-001

Penwest announces results of a phase IIa clinical study of nalbuphine ER

Positive results reported for memantine once-daily formulation study

Statistical significance achieved in phase III studies for Puricase in gout

Patient recruitment completed in phase IIa clinical trial of KUR-212 for skin grafting

FDA extends PDUFA action date for GSK's Requip XL for Parkinson's disease

Generex selects 72 clinical centers to participate in phase III study of Oral-lyn

Vaxine completes recruitment for phase I/II clinical trial of influenza vaccine

mtm Laboratories launches Cervatec assay for cervical cancer

GTC reports data from a pivotal study of ATryn for hereditary antithrombin deficiency

Recent patents report new therapeutic agents for obesity and lipoprotein disorders

Epistem and AstraZeneca report results from preliminary study of human hair biomarker technology

FDA supports favorable risk-benefit profile for Luitpold's Injectafer

Novel agents for psychological disorders disclosed in recent patent literature

Recent AstraZeneca patent describes novel antiarrhythmia agents

Promising antitumor effects with novel anti-HAAH antibody in preclinical studies

TorreyPines reports results from phase I clinical trial of tezampanel for chronic pain

Immunomedics announces results from phase I/II clinical trial of veltuzumab

Astex receives IND approval for Hsp90 inhibitor AT-13387

7TM Pharma selects new preclinical candidate for obesity and type 2 diabetes

Biovitrum and Symphogen complete phase I recombinant polyclonal antibody trial

Intercell's HCV vaccine meets primary endpoints in phase II clinical studies

Positive results reported from Nymox's U.S. study of NX-1207 for BPH

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...